Dr. Gaffar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10710 Charter Drive
#G020
Columbia, MD 21044Phone+1 410-964-2212Fax+1 410-964-0380
Education & Training
University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2002 - 2005
Rutgers Health/Robert Wood Johnson Medical SchoolChief Residency, Internal Medicine, 2001 - 2002- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1998 - 2001
Saba University School of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2002 - 2026
MD State Medical License 2005 - 2026
MO State Medical License 2020 - 2026
CO State Medical License 2024 - 2025
PA State Medical License 2006 - 2012
NJ State Medical License 2001 - 2005- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Castle Connolly Top Doctor Castle Connolly, 2022-2024
- Top Doctor Baltimore Magazine, 2017-2019
Clinical Trials
- IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2013 Apr 29
- A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer Start of enrollment: 2020 Dec 31
Publications & Presentations
PubMed
- 376 citationsNeratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3...Miguel Martin, Frankie A. Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy
The Lancet. Oncology. 2017-12-01 - 121 citationsCommunity-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma RegimensRuben Niesvizky, Ian W. Flinn, Robert M. Rifkin, Nashat Y. Gabrail, Veena Charu
Journal of Clinical Oncology. 2015-06-08
Committees
- Member, US Oncology GI Oncology Research Committee 2020 - Present
- Member, US Oncology Thoracic Oncology Committee 2020 - Present
Professional Memberships
- Member
Other Languages
- Spanish
External Links
- Biohttps://marylandoncology.com/staff/yousuf-a-gaffar-m-d-2/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
